OWENS DAVID (Chief Medical Officer) purchased 1.0% of their position (1.50K shares) of NEXALIN TECHNOLOGY, INC. on the open market
Open‑market purchase worth $4.1K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 1/29/2025ACC: 0001829126-25-000542
DirectorOfficer· Chief Medical Officer
Since Sep 2022
+1.50K
Net shares
Net buyer
$4.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.50K acquired
Non-Derivative Transactions1
Common stock
Direct
Shares
+1.50K
Price / share
$2.70
Trade value
$4.05K
% of position
1.0%
1/28/2025
152.29K→153.79K
Total
Net shares
+1.50K
Net value
$4.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 1/28/2025 | P · Purchase | +1.50K | $2.70 | $4.05K | 1.0% | 152.29K | 153.79K |
| Total | +1.50K | $4.05K | ||||||
Derivative Transactions0
No derivative transactions reported